Pioneering Organoid Research at the“Organoids Are Us”Conference in Thailand: A Collaborative Endeavor to Drive Scientific Innovation
The "Organoids Are Us" symposium, held in the picturesque setting of Pattaya, Thailand, has successfully concluded, marking a significant milestone in the field of organoid research. The International Society of Organoid Research (ISoOR) was honored to be invited and to present at the conference.
Journal of Organoid & Bioscience | Volume 2 Number 1 Live Now!
International Society of Organoid Research (ISoOR) proudly announces the publication of Volume 2, Number 1 of its esteemed journal, Journal of Organoid & Bioscience.
Innovating the Future: ISoOR 2024 Annual Meeting Achieves Remarkable Success
From March 7 to 8, 2024, the International Society of Organoid Research (ISoOR) convened its 2024 annual meeting, after the successful conference in Singapore last year.
A New Frontier in Science: ISoOR Launches Journal of Organoid & Bioscience
The International Society of Organoid Research (ISoOR) recently marked a significant advancement in the organoid field with the introduction of its new publication: Journal of Organoid & Bioscience (JOBs).
Valo Health Bags $2.7bn AI Partnership with Novo Nordisk
Novo Nordisk has paid $60 million to partner Valo Health on a project that will apply the US start-up's artificial intelligence-powered drug discovery engine to find new therapies for cardiometabolic diseases.
Valo Health Bags $2.7bn AI Partnership with Novo Nordisk
Novo Nordisk has paid $60 million to partner Valo Health on a project that will apply the US start-up's artificial intelligence-powered drug discovery engine to find new therapies for cardiometabolic diseases.
Organoids Making Their US Clinical Debut with CIDP Drug
The use of organoids in preclinical research has reached a tipping point, with U.S. FDA approval of the first drug to enter clinical trials on the basis of efficacy data derived only from these advanced cell models.
You must be logged in to post a comment.